Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Analysts

 

Pareto Securities, Dan Akschuti and Johan Unnérus

Klas Palin, Redeye

Ulrik Trattner, Carnegie

 

Calendar and upcoming reports

May 6, 2021
Erik Penser bank- Commercialization of pharmaceuticals

May 25, 2021
ABGSC Life Science Summit

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com